Clinical Trials Directory

Trials / Terminated

TerminatedNCT00512577

Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS)

Transfusion Alternatives Pre-operatively in Sickle Cell Disease

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
70 (actual)
Sponsor
NHS Blood and Transplant · Other Government
Sex
All
Age
1 Year
Healthy volunteers
Not accepted

Summary

TAPS is a sequential trial which aims to investigate whether the administration of a blood transfusion pre-operatively to patients with sickle cell disease (HB SS or Hb SB0 thal)having low or medium risk elective surgery increases or decreases the overall rate of peri-operative complications. The proportion of patients with peri-operative complications in two randomised groups of transfused and untransfused patients will be compared.

Conditions

Interventions

TypeNameDescription
OTHERRed blood cell transfusionPre-operative red blood cell transfusion

Timeline

Start date
2007-07-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2007-08-07
Last updated
2023-03-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00512577. Inclusion in this directory is not an endorsement.

Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS) (NCT00512577) · Clinical Trials Directory